background
random
trial
shown
optim
adher
antihypertens
agent
could
protect
cardiovascular
diseas
whether
adher
reduc
cardiovascular
death
commun
set
explor
fulli
studi
evalu
associ
antihypertens
adher
cardiovascular
coronari
heart
diseas
stroke
mortal
primari
care
set
method
territorywid
databas
hong
kong
includ
patient
prescrib
firstev
antihypertens
agent
year
public
healthcar
sector
patient
follow
five
year
assign
poor
proport
day
cover
pdc
b
intermedi
high
adher
antihypertens
agent
associ
antihypertens
adher
cardiovascular
mortal
evalu
use
cox
proport
hazard
model
result
total
elig
patient
patient
die
cardiovascular
diseas
within
five
year
receiv
firstev
antihypertens
agent
proport
patient
poor
intermedi
high
medic
adher
respect
higher
adher
level
pdc
hr
ci
p
b
hr
ci
p
significantli
less
like
associ
mortal
poor
adher
group
conclus
better
antihypertens
adher
associ
lower
cardiovascular
mortal
highlight
need
promot
adher
strategi
prove
effect
clinic
set
antihypertens
pharmacotherapi
effect
reduc
hypertensioninduc
complic
includ
death
trial
set
reduct
blood
pressur
lower
incid
heart
failur
stroke
myocardi
infarct
howev
wide
recogn
larg
proport
hypertens
patient
take
antihypertens
therapi
prescrib
persist
prescript
decreas
time
especi
first
year
treatment
higher
morbid
rate
mortal
hospit
rate
healthcar
cost
attribut
poor
medic
adher
recent
studi
conduct
mazzaglia
colleagu
includ
newli
diagnos
hypertens
patient
show
higher
antihypertens
adher
associ
significantli
lower
risk
acut
cardiovascular
event
hazard
ratio
hr
ci
show
even
among
experienc
event
mainten
optim
antihypertens
adher
confer
primari
prevent
substanti
extent
accompani
editori
chobanian
argu
import
investig
greater
depth
suboptim
adher
like
multifactori
one
major
determin
includ
patient
race
ethnic
turn
introduc
cultur
attitudin
differ
owe
ethnic
heterogen
data
patient
differ
ethnic
group
need
gener
find
global
context
thu
far
impact
antihypertens
persist
cardiovascular
mortal
adequ
intern
journal
cardiolog
studi
among
patient
gener
nonexperiment
clinic
set
specif
chines
popul
studi
impact
antihypertens
complianc
health
outcom
conduct
higherrisk
individu
use
cardiovascular
cv
event
alon
outcom
measur
thu
establish
effect
adher
primari
prevent
cv
mortal
even
larger
cohort
hypertens
patient
need
clinic
manag
system
cm
hong
kong
hospit
allow
opportun
studi
object
studi
test
priori
hypothesi
better
medic
adher
lead
lower
mortal
coronari
heart
diseas
stroke
larg
chines
popul
base
recent
studi
show
relationship
exist
cardiovascular
event
among
caucasian
popul
detail
descript
comprehens
territorywid
databas
hong
kong
report
previous
briefli
clinic
manag
system
consist
patient
demograph
profil
prescript
detail
clinic
inform
includ
diagnos
form
intern
classif
diseas
intern
classif
primari
care
sole
portal
inform
use
public
clinic
set
allow
linkag
inform
patient
visit
clinic
differ
district
physician
prescript
check
dispens
pharmacist
use
standard
procedur
amend
prescript
captur
databas
previou
evalu
assess
databas
report
sociodemograph
prescript
detail
complet
respect
sampl
frame
studi
includ
entir
popul
hong
kong
hong
kong
three
distinct
region
hong
kong
island
urban
kowloon
new
territori
rural
ethic
clearanc
obtain
clinic
ethic
research
committe
hospit
author
survey
behavior
research
ethic
committe
chines
univers
hong
kong
inform
consent
requir
subject
anonym
uniqu
ident
number
includ
patient
attend
consult
public
sector
prescrib
firstev
antihypertens
medic
calendar
year
index
date
detail
exclud
clinic
servic
util
substanti
disrupt
due
sever
acut
respiratori
syndrom
exclud
patient
prescrib
antihypertens
drug
index
date
treat
patient
die
due
condit
cardiovascular
diseas
within
observ
period
censor
alloc
patient
accord
initi
prescript
antihypertens
drug
name
thiazid
diuret
calcium
channel
blocker
ccb
angiotensin
convert
enzym
inhibitor
acei
prescrib
angiotensin
receptor
blocker
arb
combin
therapi
includ
analysi
number
rel
concomit
comorbid
includ
cardiovascular
risk
factor
diseas
could
potenti
influenc
choic
antihypertens
drug
class
indic
respect
code
patient
follow
occurr
cardiovascular
mortal
studi
end
five
year
outcom
variabl
includ
mortal
due
coronari
heart
diseas
cerebrovascular
diseas
among
death
hong
kong
vast
major
occur
hospit
allow
accur
case
ascertain
death
hospit
util
previou
studi
valid
measur
patient
mortal
usual
chines
popul
death
occur
hospit
predictor
variabl
studi
intervalbas
pdc
defin
number
day
medic
suppli
specifi
period
divid
total
number
day
within
period
intervalbas
pdc
intern
accept
metric
assess
medic
adher
larg
databas
analysi
pdc
indic
patient
medicationadher
studi
use
fiveyear
interv
estim
pdc
use
time
period
index
date
mortal
subject
die
adopt
approach
similar
mazzaglia
colleagu
name
classifi
drug
adher
three
level
high
pdc
intermedi
pdc
low
pdc
b
potenti
covari
control
consist
patient
age
gender
fee
payment
statu
recipi
vs
nonrecipi
public
assist
consult
primari
care
set
includ
investig
prescript
fee
cost
approxim
us
type
clinic
visit
inand
daypati
clinic
specialist
outpati
clinic
sopc
accid
emerg
depart
a
gener
outpati
clinic
gopc
clinic
type
region
resid
hong
kong
island
vs
kowloon
vs
new
territori
urban
rural
respect
number
concomit
comorbid
level
systol
blood
pressur
diastol
blood
pressur
averag
clinic
visit
use
list
comorbid
code
publish
elsewher
categor
diabet
impair
glucos
toler
cardiovascular
diseas
respiratori
diseas
renal
diseas
student
ttest
chisquar
test
heterogen
use
compar
continu
categor
variabl
respect
evalu
associ
medic
adher
high
vs
intermedi
vs
low
initi
antihypertens
drug
class
mortal
enter
variabl
list
one
coxproport
hazard
model
combin
coronari
heart
diseaseand
strokespecif
mortal
outcom
variabl
addit
observ
natur
studi
treatment
indic
bia
might
exist
therefor
addit
analysi
conduct
includ
adjust
propens
score
cox
proport
hazard
model
accord
standard
statist
methodolog
two
propens
score
model
develop
estim
weight
adher
select
name
high
vs
low
intermedi
vs
low
adher
absenc
multicollinear
evalu
ensur
robust
regress
model
statist
packag
social
scienc
spss
version
use
data
analys
pb
regard
statist
signific
total
elig
patient
includ
patient
die
coronari
heart
diseas
stroke
within
five
year
prescrib
firstev
antihypertens
agent
tabl
among
patient
death
due
coronari
heart
diseas
death
due
stroke
distribut
mortal
within
year
differ
caus
shown
fig
proport
patient
poor
intermedi
good
medic
adher
respect
among
patient
major
femal
age
year
receiv
public
assist
major
attend
inor
daypati
clinic
gener
outpati
clinic
special
outpati
clinic
significantli
patient
live
rural
region
new
territori
urban
district
betablock
ccb
commonli
prescrib
medic
follow
acei
thiazid
diuret
alphablock
major
suffer
comorbid
one
least
two
comorbid
respect
patient
higher
medic
adher
pdc
lower
incid
cardiovascular
mortal
low
adher
level
pdc
b
latter
group
similar
incid
pdc
older
patient
male
subject
receiv
public
assist
attend
inor
daypati
clinic
first
visit
set
higher
proport
die
cardiovascular
diseas
resid
rural
region
lowest
incid
cv
mortal
vs
urban
region
higher
proport
patient
prescrib
acei
ccb
firstev
prescript
die
follow
thiazid
alphablock
betablock
number
comorbid
increas
cumul
incid
cardiovascular
mortal
increas
progress
tabl
control
potenti
confound
cox
proport
hazard
regress
model
older
patient
hr
p
b
age
group
year
male
subject
hr
ci
p
b
among
femal
peopl
receiv
public
assist
hr
ci
p
b
like
suffer
cardiovascular
death
tabl
thiazid
diuret
use
refer
group
initi
prescript
acei
hr
ci
p
b
ccb
hr
ci
p
associ
higher
cv
mortal
wherea
patient
given
hr
ci
p
similarli
like
suffer
cardiovascular
death
turn
medic
adher
higher
level
pdc
hr
ci
p
b
hr
fig
distribut
mortal
differ
caus
within
year
among
studi
particip
ci
p
significantli
less
like
associ
mortal
poor
adher
pdc
b
use
refer
tabl
proport
patient
low
medium
high
medic
adher
die
coronari
heart
diseas
chd
stroke
respect
present
fig
compar
coronari
heart
diseas
stroke
mortal
signific
differ
proport
p
propens
score
differ
adher
group
appli
regress
model
similar
find
report
hr
ci
pdc
hr
ci
pdc
larg
databas
studi
chines
patient
seen
higher
medic
adher
antihypertens
agent
associ
lower
cardiovascular
mortal
addit
initi
prescript
betablock
independ
relat
lower
incid
cv
death
atrisk
factor
cv
mortal
identifi
includ
advanc
age
male
gender
poorer
socioeconom
statu
use
receipt
public
assist
proxi
measur
corrao
colleagu
util
health
servic
databas
lombardi
itali
follow
newli
treat
hypertens
patient
six
year
report
compar
patient
pdc
intermedi
pdc
high
level
pdc
adher
cv
risk
reduct
respect
mani
studi
demonstr
posit
relationship
medic
complianc
clinic
outcom
also
reflect
import
maintain
optim
medic
adher
studi
differ
studi
number
respect
includ
fact
includ
differ
patient
group
diabet
patient
preexist
myocardi
infarct
coronari
heart
diseas
differ
medic
studi
like
cardiovascular
drug
antihypertens
agent
differ
clinic
outcom
measur
like
cardiovascular
event
heart
failur
instead
cv
mortal
hospit
risk
healthcar
cost
use
selfreport
data
measur
adher
furthermor
studi
predominantli
base
patient
caucasian
ethnic
group
higher
incid
coronari
heart
diseas
lower
risk
stroke
chines
subject
preval
hypertens
rise
rapidli
differ
urban
rural
region
china
adher
antihypertens
medic
among
chines
remain
poor
instanc
recent
studi
found
preval
hypertens
southern
china
increas
urban
region
rate
awar
treatment
control
low
respect
rural
region
china
adher
rate
antihypertens
treatment
found
among
elderli
chines
american
similarli
poor
adher
level
also
observ
chines
popul
factor
identifi
associ
higher
cv
risk
name
advanc
age
male
gender
poorer
socioeconom
statu
extens
support
previou
literatur
find
prescript
acei
ccb
associ
higher
cv
mortal
could
explain
fact
newer
antihypertens
agent
commonli
prescrib
patient
concomit
comorbid
instanc
patient
diabet
chronic
kidney
diseas
like
receiv
acei
physician
might
avoid
prescrib
thiazid
diuret
patient
exist
dyslipidemia
use
ccb
acei
firstlin
agent
instead
one
find
worthi
notepati
high
level
adher
pdc
hazard
ratio
closer
one
compar
patient
pdc
rang
despit
use
propens
score
control
treatment
indic
bia
believ
could
caus
presenc
residu
confoundinga
possibl
condit
might
sicker
patient
higher
risk
cv
mortal
intens
drugtak
monitor
hitherto
largest
observ
studi
evalu
relationship
antihypertens
adher
clinic
outcom
asian
report
clear
invers
relationship
medic
adher
cv
mortal
reallif
clinic
practic
larg
sampl
size
follow
five
year
comprehens
computer
system
complet
clinic
inform
among
studi
strength
addit
good
dispens
practic
captur
comput
enhanc
robust
studi
find
nevertheless
limit
discuss
firstli
exist
inher
limit
databas
analysi
name
assumpt
patient
actual
take
medic
prescrib
addit
healthcar
system
hong
kong
consist
public
privat
sector
studi
captur
data
patient
visit
clinic
set
privat
marketalthough
hypertens
patient
follow
public
sector
medic
refil
also
abl
studi
cardiovascular
outcom
five
year
confound
could
control
studi
exist
possibl
residu
confound
despit
regress
analysi
issu
treatment
indic
bia
could
still
remain
despit
introduct
propens
score
could
argu
adher
better
medic
could
also
sickerand
henc
significantli
higher
risk
cardiovascular
diseas
studi
strengthen
notion
better
medic
adher
would
protect
cardiovascular
mortal
intervent
set
also
actual
clinic
practic
fill
knowledg
gap
exist
literatur
scarc
address
associ
nonintervent
set
result
concret
evid
support
intens
counsel
medic
adher
initi
physician
alli
health
profession
hypertens
patient
clinic
consult
healthpolici
level
greater
need
communitybas
program
strategi
enhanc
complianc
justifi
find
mani
innov
approach
enhanc
medic
adher
includ
comprehens
multimod
pharmaci
care
initi
demonstr
effect
improv
drug
adher
addit
higher
risk
medic
nonadher
name
younger
patient
femal
subject
peopl
lower
socioeconom
statu
patient
without
concomit
comorbid
receiv
particular
attent
futur
research
focu
evalu
associ
ethnic
group
patient
differ
cardiovascular
risk
well
identifi
patient
subgroup
impact
enhanc
medic
adher
strongest
summari
studi
extend
understand
posit
impact
antihypertens
medic
adher
cardiovascular
mortal
addit
cardiovascular
event
also
strengthen
use
medic
adher
outcom
variabl
proxi
cardiovascular
outcom
studi
mortal
data
easili
collect
studi
concur
recommend
mazzaglia
et
al
systemat
effort
improv
medic
adher
would
provid
even
concret
clinic
benefit
